You have 9 free searches left this month | for more free features.

Initial Diagnosed Unresectable Locally Advanced Stage

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)

Recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 26, 2023

Lung Cancer, Stage III Lung Cancer, Unresectable Lung Carcinoma Trial in Barcelona (procedure, diagnostic test, drug)

Recruiting
  • Lung Cancer
  • +2 more
  • Sample collection
  • +3 more
  • Barcelona, Spain
    Parc de Salut Mar - Hospital del Mar
Dec 8, 2022

Immunotherapy in Conversion Therapy of Unresectable Gastric

Recruiting
  • Unresectable Gastric Cancer
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Nov 8, 2022

    Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)

    Not yet recruiting
    • Stage III Non-small Cell Lung Cancer
    • +2 more
    • standard Radiotherapy
    • +3 more
    • (no location specified)
    Oct 20, 2023

    Esophageal Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (LBL-007,

    Not yet recruiting
    • Esophageal Cancer
    • +2 more
    • (no location specified)
    Aug 21, 2023

    Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

    Recruiting
    • Nonsmall Cell Lung Cancer
    • +3 more
    • Genomically Guided Radiation Therapy (RT)
    • Tampa, Florida
      Moffitt Cancer Center
    May 23, 2023

    CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes

    Recruiting
    • Unresectable /Inoperable Locally Advanced (Stage II-III) Non-small Cells Lung Cancer (NSCLC)
      • Grozny, Russian Federation
      • +4 more
      May 31, 2023

      BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

      Withdrawn
      • BCLC Stage B Hepatocellular Carcinoma
      • +4 more
      • Atezolizumab
      • +3 more
      • (no location specified)
      Dec 12, 2022

      Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer American Joint Committee on Cancer v8, Unresectable

      Not yet recruiting
      • Locally Advanced Pancreatic Adenocarcinoma
      • +2 more
      • Biospecimen Collection
      • +8 more
      • Los Angeles, California
        USC / Norris Comprehensive Cancer Center
      Nov 9, 2023

      Metastatic Carcinoma in the Adrenal Cortex, Stage III Adrenal Cortex Carcinoma AJCC v8, Stage IV Adrenal Cortex Carcinoma AJCC

      Active, not recruiting
      • Metastatic Carcinoma in the Adrenal Cortex
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 12, 2022

      BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

      Recruiting
      • BCLC Stage B Hepatocellular Carcinoma
      • +9 more
      • Durvalumab
      • Tremelimumab
      • Duarte, California
        City of Hope Medical Center
      Aug 15, 2022

      Locally Advanced Unresectable Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8

      Recruiting
      • Locally Advanced Pancreatic Carcinoma
      • +3 more
      • Biopsy
      • +5 more
      • Ann Arbor, Michigan
        University of Michigan Comprehensive Cancer Center EDDOP
      Nov 30, 2022

      NSCLC Trial in Worldwide (Alectinib, Entrectinib, Pralsetinib)

      Recruiting
      • Non-Small Cell Lung Cancer
      • San José, Costa Rica
      • +3 more
      Aug 4, 2022

      Locally Advanced Adrenal Cortical Carcinoma, Metastatic Adrenal Cortical Carcinoma, Stage III Adrenal Cortical Carcinoma AJCC v8

      Not yet recruiting
      • Locally Advanced Adrenal Cortical Carcinoma
      • +4 more
      • Atezolizumab
      • +5 more
      • Atlanta, Georgia
      • +1 more
      Aug 17, 2023

      NSCLC Stage III Trial in Hefei (Envafolimab)

      Not yet recruiting
      • Non-small Cell Lung Cancer Stage III
      • Hefei, Anhui, China
        Anhui Provincial Cancer Hospital
      Jun 8, 2022

      NSCLC Stage III, EGFR Positive NSCLC, Non-squamous Non-small-cell Lung Cancer Trial in Korea, Republic of (Lazertinib)

      Recruiting
      • Non-small Cell Lung Cancer Stage III
      • +2 more
      • Busan, Korea, Republic of
      • +12 more
      Jan 17, 2023

      Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III

      Recruiting
      • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
      • +10 more
      • Biopsy
      • +8 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jan 20, 2023

      Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

      Not yet recruiting
      • Locally Advanced Intrahepatic Cholangiocarcinoma
      • +4 more
      • Angiography
      • +8 more
      • Jacksonville, Florida
        Mayo Clinic in Florida
      Sep 22, 2023

      Colorectal Carcinoma Trial (Pembrolizumab)

      Completed
      • Colorectal Carcinoma
      • Pembrolizumab
      • (no location specified)
      Mar 29, 2022

      Locally Advanced Lung Non-Small Cell Carcinoma Trial in Terni (Stereotactic Ablative Radiotherapy in Unresectable Locally

      Completed
      • Locally Advanced Lung Non-Small Cell Carcinoma
      • Stereotactic Ablative Radiotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer
      • Terni, TR, Italy
        Radiotherapy Oncology Centre "S.Maria" Hospital
      Mar 22, 2022

      Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

      Active, not recruiting
      • Advanced Soft Tissue Sarcoma
      • +26 more
      • Doxorubicin Hydrochloride
      • +3 more
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Jan 6, 2023

      NSCLC, Stage III Trial in Chengdu (GFH018, Toripalimab, Paclitaxel)

      Not yet recruiting
      • NSCLC, Stage III
      • Chengdu, Sichuan, China
        West China Hospital, Sichuan University
      May 23, 2022

      Advanced Pancreatic Carcinoma, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Trial in Rochester

      Recruiting
      • Advanced Pancreatic Carcinoma
      • +9 more
      • Endoscopic Ultrasound
      • +4 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Dec 13, 2022

      Advanced Melanoma Trial in Beijing (JS001+Imatinib mesylate)

      Recruiting
      • Advanced Melanoma
      • JS001+Imatinib mesylate
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Mar 2, 2022

      Stage III Non-small-cell Lung Cancer Trial in Foshan, Guangzhou (other, radiation, drug)

      Recruiting
      • Stage III Non-small-cell Lung Cancer
      • Neoadjuvant therapy
      • +4 more
      • Foshan, Guangdong, China
      • +2 more
      Oct 25, 2022